Boniatti, J.; Januskaite, P.; Fonseca, L.B.d.; Viçosa, A.L.; Amendoeira, F.C.; Tuleu, C.; Basit, A.W.; Goyanes, A.; Ré, M.-I.
Direct Powder Extrusion 3D Printing of Praziquantel to Overcome Neglected Disease Formulation Challenges in Paediatric Populations. Pharmaceutics 2021, 13, 1114.
https://doi.org/10.3390/pharmaceutics13081114
AMA Style
Boniatti J, Januskaite P, Fonseca LBd, Viçosa AL, Amendoeira FC, Tuleu C, Basit AW, Goyanes A, Ré M-I.
Direct Powder Extrusion 3D Printing of Praziquantel to Overcome Neglected Disease Formulation Challenges in Paediatric Populations. Pharmaceutics. 2021; 13(8):1114.
https://doi.org/10.3390/pharmaceutics13081114
Chicago/Turabian Style
Boniatti, Janine, Patricija Januskaite, LaÃs B. da Fonseca, Alessandra L. Viçosa, Fábio C. Amendoeira, Catherine Tuleu, Abdul W. Basit, Alvaro Goyanes, and Maria-Inês Ré.
2021. "Direct Powder Extrusion 3D Printing of Praziquantel to Overcome Neglected Disease Formulation Challenges in Paediatric Populations" Pharmaceutics 13, no. 8: 1114.
https://doi.org/10.3390/pharmaceutics13081114
APA Style
Boniatti, J., Januskaite, P., Fonseca, L. B. d., Viçosa, A. L., Amendoeira, F. C., Tuleu, C., Basit, A. W., Goyanes, A., & Ré, M.-I.
(2021). Direct Powder Extrusion 3D Printing of Praziquantel to Overcome Neglected Disease Formulation Challenges in Paediatric Populations. Pharmaceutics, 13(8), 1114.
https://doi.org/10.3390/pharmaceutics13081114